Terms: = Liver cancer AND SERPINE1, PAI, PAI-1, PAI1, PLANH1 AND Prognosis
37 results:
1. Diagnostic role and immune correlates of programmed cell death-related genes in hepatocellular carcinoma.
He Z; Zhang J; Huang W
Sci Rep; 2023 Nov; 13(1):20509. PubMed ID: 37993470
[TBL] [Abstract] [Full Text] [Related]
2. Identification of cancer-associated fibroblasts signature for predicting the prognosis and immunotherapy response in hepatocellular carcinoma.
Ye J; Tian W; Zheng B; Zeng T
Medicine (Baltimore); 2023 Nov; 102(45):e35938. PubMed ID: 37960718
[TBL] [Abstract] [Full Text] [Related]
3. Based on network pharmacology and experiments to explore the underlying mechanism of Mahonia bealei (Fortune) Carrière for treating alcoholic hepatocellular carcinoma.
Zhang N; Zhu Y; Zhang X; Yang K; Yang X; An M; Tian C; Li J
J Ethnopharmacol; 2024 Jan; 318(Pt A):116919. PubMed ID: 37453621
[TBL] [Abstract] [Full Text] [Related]
4. An Inflammation-Associated prognosis Model for Hepatocellular Carcinoma Based on Adenylate Uridylate- (AU-) Rich Element Genes.
Song L; Su X; Lu Y; Hua D; Gao Z
Mediators Inflamm; 2023; 2023():2613492. PubMed ID: 37181805
[TBL] [Abstract] [Full Text] [Related]
5. Construction of a Combined Hypoxia-related Genes Model for Hepatocellular Carcinoma prognosis.
Ren L; Pan X; Ning L; Gong D; Huang J; Deng K; Xie L; Zhang Y
Curr Comput Aided Drug Des; 2023; 19(2):150-161. PubMed ID: 36567292
[TBL] [Abstract] [Full Text] [Related]
6. High expression of syndecan-4 is related to clinicopathological features and poor prognosis of pancreatic adenocarcinoma.
Zhu Y; Zheng D; Lei L; Cai K; Xie H; Zheng J; Yu C
BMC Cancer; 2022 Oct; 22(1):1042. PubMed ID: 36199068
[TBL] [Abstract] [Full Text] [Related]
7. Integrated transcriptome and in vitro analysis revealed anti-proliferative effect of sodium perborate on hepatocellular carcinoma cells.
Omeroglu Ulu Z; Bolat ZB; Sahin F
J Trace Elem Med Biol; 2022 Sep; 73():127011. PubMed ID: 35716648
[TBL] [Abstract] [Full Text] [Related]
8. A multifunctional targeted nanoprobe with high NIR-II pai/MRI performance for precise theranostics of orthotopic early-stage hepatocellular carcinoma.
He L; Zhang Y; Chen J; Liu G; Zhu J; Li X; Li D; Yang Y; Lee CS; Shi J; Yin C; Lai P; Wang L; Fang C
J Mater Chem B; 2021 Nov; 9(42):8779-8792. PubMed ID: 34635903
[TBL] [Abstract] [Full Text] [Related]
9. liver-Metastasis-Related Genes are Potential Biomarkers for Predicting the Clinical Outcomes of Patients with Pancreatic Adenocarcinoma.
Dong Y; Tian J; Yan B; Lv K; Li J; Fu D
Pathol Oncol Res; 2021; 27():1609822. PubMed ID: 34290570
[TBL] [Abstract] [Full Text] [Related]
10. cancer‑associated fibroblast‑induced M2‑polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor‑1 pathway.
Chen S; Morine Y; Tokuda K; Yamada S; Saito Y; Nishi M; Ikemoto T; Shimada M
Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195849
[TBL] [Abstract] [Full Text] [Related]
11. Evaluation of p53 and Its Target Gene Expression as Potential Biomarkers of Cholangiocarcinoma in Thai Patients.
Puetkasichonpasutha J; Namwat N; Sa-Ngiamwibool P; Titapun A; Suthiphongchai T
Asian Pac J Cancer Prev; 2020 Mar; 21(3):791-798. PubMed ID: 32212809
[TBL] [Abstract] [Full Text] [Related]
12. Expression, clinicopathologic and prognostic significance of plasminogen activator inhibitor 1 in hepatocellular carcinoma.
Jin Y; Liang ZY; Zhou WX; Zhou L
Cancer Biomark; 2020; 27(3):285-293. PubMed ID: 31640087
[TBL] [Abstract] [Full Text] [Related]
13. The microRNA-15a-pai-2 axis in cholangiocarcinoma-associated fibroblasts promotes migration of cancer cells.
Utaijaratrasmi P; Vaeteewoottacharn K; Tsunematsu T; Jamjantra P; Wongkham S; Pairojkul C; Khuntikeo N; Ishimaru N; Sirivatanauksorn Y; Pongpaibul A; Thuwajit P; Thuwajit C; Kudo Y
Mol Cancer; 2018 Jan; 17(1):10. PubMed ID: 29347950
[TBL] [Abstract] [Full Text] [Related]
14. Up-Regulation of pai-1 and Down-Regulation of uPA Are Involved in Suppression of Invasiveness and Motility of Hepatocellular Carcinoma Cells by a Natural Compound Berberine.
Wang X; Wang N; Li H; Liu M; Cao F; Yu X; Zhang J; Tan Y; Xiang L; Feng Y
Int J Mol Sci; 2016 Apr; 17(4):577. PubMed ID: 27092498
[TBL] [Abstract] [Full Text] [Related]
15. Silencing of plasminogen activator inhibitor-1 suppresses colorectal cancer progression and liver metastasis.
Chen H; Peng H; Liu W; Sun Y; Su N; Tang W; Zhang X; Wang J; Cui L; Hu P; Liu S
Surgery; 2015 Dec; 158(6):1704-13. PubMed ID: 26275833
[TBL] [Abstract] [Full Text] [Related]
16. Expression of deleted in liver cancer 1 and plasminogen activator inhibitor 1 protein in ovarian carcinoma and their clinical significance.
Ren F; Shi H; Zhang G; Zhang R
J Exp Clin Cancer Res; 2013 Aug; 32(1):60. PubMed ID: 23988121
[TBL] [Abstract] [Full Text] [Related]
17. Low expression of pai-2 as a novel marker of portal vein tumor thrombosis and poor prognosis in hepatocellular carcinoma.
Zhou L; Jin Y; Cui QC; Jin KM; Zhou WX; Xing BC
World J Surg; 2013 Mar; 37(3):608-13. PubMed ID: 23188538
[TBL] [Abstract] [Full Text] [Related]
18. Stable isotope labeling with amino acids in cell culture (SILAC)-based quantitative proteomics study of a thyroid hormone-regulated secretome in human hepatoma cells.
Chen CY; Chi LM; Chi HC; Tsai MM; Tsai CY; Tseng YH; Lin YH; Chen WJ; Huang YH; Lin KH
Mol Cell Proteomics; 2012 Apr; 11(4):M111.011270. PubMed ID: 22171322
[TBL] [Abstract] [Full Text] [Related]
19. Evaluation of the association of urokinase plasminogen activator system gene polymorphisms with susceptibility and pathological development of hepatocellular carcinoma.
Weng CJ; Tsai CM; Chen YC; Hsieh YH; Lin CW; Liu YF; Su SC; Chen MK; Yang SF
Ann Surg Oncol; 2010 Dec; 17(12):3394-401. PubMed ID: 20706793
[TBL] [Abstract] [Full Text] [Related]
20. Emodin inhibits the growth of hepatoma cells: finding the common anti-cancer pathway using Huh7, Hep3B, and HepG2 cells.
Hsu CM; Hsu YA; Tsai Y; Shieh FK; Huang SH; Wan L; Tsai FJ
Biochem Biophys Res Commun; 2010 Feb; 392(4):473-8. PubMed ID: 19895793
[TBL] [Abstract] [Full Text] [Related]
[Next]
